Northeast chain praised for health initiatives
Health-and-wellness initiatives have become one of the latest rages among retailers, particularly supermarket pharmacies, and Hannaford Supermarkets has made it a point to lead the way.
Owned by Belgian supermarket operator Delhaize Group, Scarborough, Maine-based Hannaford operates 173 stores throughout New England, of which 120 have pharmacies. Those pharmacies have achieved high rankings among consumers.
Headquarters: Scarborough, Maine2009 sales: $4.3 billion% change vs. 2008: 3%No. of stores: 173No. of stores with Rx: 120Avg. store size: 34,000 sq. ft.Rx sales: $387 million% of sales from Rx: 9%Sales per store: $24.9 millionSource: Drug Store News
In June 2009, Hannaford announced that a survey of consumers showed that its supermarket pharmacies ranked highest among store chains in the Northeast, beating Stop & Shop, ShopRite and Wegmans with a score of 90 out of 100. The survey was based on responses from 40,133 consumers who bought prescription drugs in walk-in stores between April 2006 and April 2007, and focused on such aspects of pharmacy as service, knowledge, speed and medicine availability. The article also praised Hannaford’s generic drug discount program, which sells 30-day supplies of generics for $4.
The chain’s health initiatives have received accolades as well. In July, the National Business Group on Health named Hannaford a platinum-level organization in the Best Employers for Healthy Lifestyle Awards, which NBGH presents annually to employers that it determines have shown effective efforts to improve the health of employees and their families.
Schnucks’ O’Brien to serve on Department of Agriculture advisory committee
ST. LOUIS An executive from Schnuck Markets will serve on an advisory committee of the Department of Agriculture, Schnucks said this week.
Agriculture secretary Tom Vilsack announced that Schnucks VP produce and floral Mike O’Brien would be one of 25 people appointed to a two-year term on the USDA’s Fruit and Vegetable Industry Advisory Committee. O’Brien is also vice chairman of the Produce Marketing Association.
“I am honred to represent Schnuck Markets and the retail produce industry as a member of this committee,” O’Brien said. “I am looking forward to the opportunity to contribute and to make a difference for families across the nation.”
The committee, originally chartered in 2001, advises the secretary of agriculture on industry issues related to fruits and vegetables.
Gilead commences phase 3 trial for single-tablet HIV treatment
FOSTER CITY, Calif. Gilead Sciences has started a late-stage clinical trial of an investigational 4-in-1 treatment for HIV, the drug maker said.
Gilead announced the initiation of a phase 3 trial of its “Quad” HIV drug, a single-tablet treatment that combines elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate. The study will compare the Quad regimen with the standard of care among adults with HIV-1 who have not taken antiretroviral treatments. The company is also investigating cobicistat as a standalone boosting agent for antiretroviral drugs.
“We are pleased to announce that the Quad phase 3 clinical program is underway,” Gilead EVP research and development and chief scientific officer Norbert Bischofberger said. “Efficacy and safety results from the phase 2 study suggest that the Quad may represent an important new option for patients with HIV.”